ArticleCurrent pharmacogenomics and personalized medicine2009

Personalizing HER2-targeted therapy in metastatic breast cancer beyond HER2 status: what we have learned from clinical specimens.

R Nahta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.